Aspire Transitional Care in Flagstaff, AZ

Aspire Transitional Care is a medicare certified nursing home in Flagstaff, Arizona. It is located in Coconino county at 1521 North Pine Cliff Drive, Flagstaff, Arizona 86001. You can reach out to the office of Aspire Transitional Care via phone at (928) 440-2350. This skilled nursing facility has 50 federally certified beds with average occupancy rate of 47.2%. Its legal business name is Flagstaff Transitional Care, Llc and has the following ownership type - For Profit - Corporation.

Aspire Transitional Care (Medicare CCN 035296) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in medicare program. This means if you are part of medicare program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 2018 (6 years certified) and the last quality survey was conducted in November, 2019.

Name	Aspire Transitional Care
Location	1521 North Pine Cliff Drive, Flagstaff, Arizona
Certified By	Medicare
No. of Certified Beds	50
Occupancy Rate	47.2%
Medicare ID (CCN)	035296
Legal Business Name	Flagstaff Transitional Care, Llc
Ownership Type	For Profit - Corporation

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Aspire Transitional Care from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1407482920
Organization Name	FLAGSTAFF TRANSITIONAL CARE, LLC
Doing Business As	ASPIRE TRANSITIONAL CARE
Address	1521 N Pine Cliff Dr, Flagstaff, AZ 86001
Phone Number	928-440-2350

News Archive

Amarillo Biosciences is midway in Phase 2 clinical study of interferon against H1N1

Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that a Phase 2 study of orally administered interferon-alpha for the prevention of influenza and winter colds has reached the midway point. The study in Perth, Australia achieved full target enrollment of 200 subjects and 98% of the subjects remain on study drug. Subjects in the study are receiving a lozenge containing interferon-alpha or a matching placebo once a day for 16 weeks.

Inovalon, Walgreens sign agreement to bring innovative solutions to healthcare marketplace

Inovalon, Inc., a leading provider of data-driven healthcare solutions, and Walgreens, the nation's largest drugstore chain, today announced that they have entered into a multi-year agreement to provide Inovalon's data-driven encounter support platform, Electronic Patient Assessment Solution Suite within Healthcare Clinic at select Walgreens to support improvements in managed care quality and performance.

NCD draft declaration lacks specific targets, calls for nations to adopt recommendations for reducing chronic disease deaths

"World leaders at a meeting of the United Nations on Monday will agree to a deal to try to curb the spread of preventable 'lifestyle' diseases," including heart disease, cancers and diabetes, also known as non-communicable diseases (NCDs), "amid concern that progress is already being hampered by powerful lobbyists from the food, alcohol and tobacco industries," the Guardian reports.

FDA to have greater tobacco and cigarette control

Starting Tuesday, June 22 the Food and Drug Administration will have far greater control over how tobacco and cigarettes are marketed, distributed and sold. The announcement on Thursday, March 18 was made by Kathleen Sebelius, the US Health and Human Services Secretary.

Read more Medical News

› Verified 2 days ago

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Aspire Transitional Care are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Aspire Transitional Care give to their patients.

Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

Amarillo Biosciences is midway in Phase 2 clinical study of interferon against H1N1

Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that a Phase 2 study of orally administered interferon-alpha for the prevention of influenza and winter colds has reached the midway point. The study in Perth, Australia achieved full target enrollment of 200 subjects and 98% of the subjects remain on study drug. Subjects in the study are receiving a lozenge containing interferon-alpha or a matching placebo once a day for 16 weeks.

Inovalon, Walgreens sign agreement to bring innovative solutions to healthcare marketplace

Inovalon, Inc., a leading provider of data-driven healthcare solutions, and Walgreens, the nation's largest drugstore chain, today announced that they have entered into a multi-year agreement to provide Inovalon's data-driven encounter support platform, Electronic Patient Assessment Solution Suite within Healthcare Clinic at select Walgreens to support improvements in managed care quality and performance.

NCD draft declaration lacks specific targets, calls for nations to adopt recommendations for reducing chronic disease deaths

"World leaders at a meeting of the United Nations on Monday will agree to a deal to try to curb the spread of preventable 'lifestyle' diseases," including heart disease, cancers and diabetes, also known as non-communicable diseases (NCDs), "amid concern that progress is already being hampered by powerful lobbyists from the food, alcohol and tobacco industries," the Guardian reports.

FDA to have greater tobacco and cigarette control

Starting Tuesday, June 22 the Food and Drug Administration will have far greater control over how tobacco and cigarettes are marketed, distributed and sold. The announcement on Thursday, March 18 was made by Kathleen Sebelius, the US Health and Human Services Secretary.

Read more Medical News

› Verified 2 days ago

Number of Facility Reported Incidents	0
Number of Substantiated Complaints	0
Number of Fines	1
Total Amount of Fines in Dollars	$650
Number of Payment Denials	0
Total Number of Penalties	1

The resident survey data of Aspire Transitional Care is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience Measure	Provider	National Avg.